OKYO Pharma (OKYO) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
OKYO Pharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $119K and 0 sold $0 of OKYO stock on the open market, including a cluster buy that began Jul 20, 2026.
Get emailed when insiders cluster-buy stocks like OKYO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
OKYO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $136K | 7 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 OKYO Pharma Ltd insiders reported open-market purchases totaling $119K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Jul 20, 2026, when 3 insiders bought a combined $119K.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 7SEC | Gabriele M CerroneDirector | Buy | 25,00010,851,416 held (+0%) | $1.40 | $35K | +1.4% | — |
| Aug 7SEC | Gabriele M CerroneDirector | Buy | 22,50010,873,916 held (+0%) | $1.45 | $33K | -2.1% | — |
| Aug 7SEC | Flavio MantelliChief Medical Officer | Buy | 20,000new position | $1.40 | $28K | +1.4% | — |
| Aug 7SEC | Robert John DempseyCEO | Buy | 15,000new position | $1.54 | $23K | -7.8% | — |
| Aug 7SEC | John P BrancaccioDirector | Buy | 5,00035,201 held (+17%) | $1.48 | $7K | -4.1% | — |
| Aug 7SEC | Rajkumar V. PatilChief Scientific Officer | Buy | 3,36320,030 held (+20%) | $1.49 | $5K | -4.7% | — |
| Aug 7SEC | Gary S JacobChief Development Officer | Buy | 3,500112,420 held (+3%) | $1.40 | $5K | +1.4% | — |
Insiders at OKYO Pharma Ltd
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Gabriele M CerroneDirector | $68K | — | Aug 7, 2026 | — |
| Flavio MantelliChief Medical Officer | $28K | — | Aug 7, 2026 | — |
| Robert John DempseyCEO | $23K | — | Aug 7, 2026 | — |
| John P BrancaccioDirector | $7K | — | Aug 7, 2026 | — |
| Rajkumar V. PatilChief Scientific Officer | $5K | — | Aug 7, 2026 | — |
| Gary S JacobChief Development Officer | $5K | — | Aug 7, 2026 | — |
OKYO stock: common questions
Are OKYO Pharma Ltd insiders buying OKYO stock?
In the past 12 months, 3 insiders reported open-market purchases of OKYO worth $119K. The latest was Director Gabriele M Cerrone bought $35K of OKYO at $1.40 — first open-market purchase in our records.
Are OKYO Pharma Ltd insiders selling OKYO stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is OKYO's 52-week range?
Over the past year OKYO has traded between $1.29 and $3.11. It last closed at $1.42 on Oct 9, 2026.